Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Reducing sore throat after thyroid or parathyroid surgery

Official title: Effect of Hydrocortisone and Lidocaine on Endotracheal Tube for Sore Throat and Hoarseness After Thyroid/Parathyroid Surgery With Neuromonitoring: A Randomized Controlled Trial

Run by Saint Petersburg State University, Russia · NCT07124650 · Data updated 2026-11-12

This test will try whether coating the breathing tube with hydrocortisone ointment or lidocaine solution reduces throat pain, hoarseness, and cough in adults having elective thyroid or parathyroid surgery with neuromonitoring.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment764 (estimated)
SponsorSaint Petersburg State University, Russia
Academic / other
Locations1 site (Saint Petersburg)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedDecember 2026
Study endsMay 2027
Registry record updatedApril 13, 2026
Trial IDNCT07124650 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for elective open thyroid or parathyroid surgery with intraoperative neuromonitoring who can give informed consent and do not have allergies to the study drugs.

Probably not a fit

Patients who are pregnant, allergic to hydrocortisone or lidocaine, children, or those undergoing emergency or non-neck surgeries are unlikely to benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-center trial will enroll 764 adults undergoing elective open thyroid or parathyroid surgery with intraoperative neuromonitoring and randomly assign them to receive an endotracheal tube coated with either hydrocortisone 1% ointment or lidocaine 0.05% with chlorhexidine. The coated tube will be used during standard anesthesia and surgery, and patients will be monitored per routine clinical care. Outcomes — throat pain, hoarseness, and cough — will be measured on awakening, at 24 hours, and at 3 days postoperatively. Results aim to inform simple, low-cost measures to improve early postoperative comfort after these procedures.

Why it matters

Potential benefit: If successful, the coating could reduce immediate postoperative throat pain, hoarseness, and coughing, improving patient comfort and early recovery.

How similar studies have gone: Previous randomized trials and meta-analyses have shown that topical corticosteroids or lidocaine on endotracheal tubes can reduce postoperative sore throat and hoarseness, though lidocaine results have been mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for elective open surgery on the thyroid/parathyroid glands with intraoperative neuromonitoring.
* Age ≥18 years.
* Willing and able to provide voluntary informed consent for participation in the study.

Exclusion Criteria:

* Pregnancy (for women of childbearing potential).
* Known allergy to hydrocortisone or lidocaine.
* Refusal to participate in the study.

Where it's running

  • Saint Petersburg State University Hospital
    Saint Petersburg, Russia
    Recruiting

Study contacts

  • Principal investigator: Sergey M. Efremov, MD, PhD — Saint Petersburg State University Hospital
  • Study coordinator: Sergey M. Efremov, D. Med. Sc.
  • Email: efremovsergm@gmail.com
  • Phone: +79137946090

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.